Supplemental material
Bioengineered
Volume 13, 2022 - Issue 2
Open access
1,336
Views
1
CrossRef citations to date
0
Altmetric
Research Paper
Eukaryotic translation initiation factor 3 subunit B could serve as a potential prognostic predictor for breast cancer
Shaoran Songa Center for Translational Medicine, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China;b The Key Laboratory for Tumor Precision Medicine of Shaanxi Province, The First Affiliated Hospital, Xi’an Jiaotong University, Xi’an, ShaanxiChinaView further author information
, Jie Liua Center for Translational Medicine, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China;b The Key Laboratory for Tumor Precision Medicine of Shaanxi Province, The First Affiliated Hospital, Xi’an Jiaotong University, Xi’an, ShaanxiChinaView further author information
, Miao Zhanga Center for Translational Medicine, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China;b The Key Laboratory for Tumor Precision Medicine of Shaanxi Province, The First Affiliated Hospital, Xi’an Jiaotong University, Xi’an, ShaanxiChinaView further author information
, Xiaoqian Gaoa Center for Translational Medicine, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China;b The Key Laboratory for Tumor Precision Medicine of Shaanxi Province, The First Affiliated Hospital, Xi’an Jiaotong University, Xi’an, ShaanxiChinaView further author information
, Wei Suna Center for Translational Medicine, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China;b The Key Laboratory for Tumor Precision Medicine of Shaanxi Province, The First Affiliated Hospital, Xi’an Jiaotong University, Xi’an, ShaanxiChinaView further author information
, Peijun Liua Center for Translational Medicine, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China;b The Key Laboratory for Tumor Precision Medicine of Shaanxi Province, The First Affiliated Hospital, Xi’an Jiaotong University, Xi’an, ShaanxiChinaView further author information
, Yaochun Wanga Center for Translational Medicine, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China;b The Key Laboratory for Tumor Precision Medicine of Shaanxi Province, The First Affiliated Hospital, Xi’an Jiaotong University, Xi’an, ShaanxiChinaView further author information
& Juan Lia Center for Translational Medicine, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China;b The Key Laboratory for Tumor Precision Medicine of Shaanxi Province, The First Affiliated Hospital, Xi’an Jiaotong University, Xi’an, ShaanxiChinaCorrespondence[email protected]
View further author information
show allView further author information
Pages 2762-2776
|
Received 16 Oct 2021, Accepted 07 Dec 2021, Published online: 18 Jan 2022
Related Research Data
Eukaryotic translation initiation factor 3 subunit B could serve as a potential prognostic predictor for breast cancer
Source:
Taylor & Francis
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.